GPs told to end “chemical restraint” of people with learning disabilities
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3137 (Published 03 June 2016) Cite this as: BMJ 2016;353:i3137- Anne Gulland
- London
GPs have been urged to cut the number of inappropriate prescriptions of psychotropic drugs for people with learning disabilities.
New guidance from NHS England and the Royal College of General Practitioners encouraged GPs to review prescriptions for patients with learning disabilities or autism, and make sure that psychotropic drugs were only continued where the person posed a severe risk to themselves or others, and all other alternatives had been exhausted.1
According to a review of the prescribing of drugs to people with learning disabilities published last year, between …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.